Clinical Trial Update: Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating endoscopic botulinum toxin injection to prevent postoperative pancreatic fistula after distal pancreatectomy was terminated, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pancreatic Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-05-13